Zheng Kuang

4PUBLICATIONS
64CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Mar 02, 2023
POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2.

Matthew C Hiemenz, Jaspreet Kaur, Zheng Kuang

|Jan 23, 2023
Genomic landscape of 891 RET fusions detected across diverse solid tumor types.

Vamsi Parimi, Khaled Tolba, Natalie Danziger

|Jan 09, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.

Emily L Hoskins, Eric Samorodnitsky, Michele R Wing

Pageof 1